Author(s): McInnes GT
Abstract Share this page
Abstract Control of systolic blood pressure should be the primary goal of treatment as it is increasingly recognized as a major determinant of cardiovascular risk. Better control offers enormous potential benefits. Effective treatment is desirable but difficult to achieve. All antagonists, particularly eprosartan, are likely to have an increasingly important role in management strategies.
This article was published in Hosp Med
and referenced in Pharmaceutica Analytica Acta